Increasing focus of key players the development and commercialization of new sclerosants which can be used in the treatment of varicose veins such as sodium tetradecyl sulfate, hypertonic saline, and polidocanol is driving the growth of the micro sclerotherapy treatment market. Key players are engaged in inorganic growth strategies such as mergers and acquisitions which is again fostering the growth of the micro sclerotherapy treatment market. For instance, in August 2019, Boston Scientific acquired BTG International, Inc as BTG manufactures and commercializes products used in minimally invasive treatments used for targeting cancer and other vascular diseases.
Major players engaged in the global microsclerotherapy treatment market are Surgimedix, Inc., Merz Pharma GmbH & Co. KGaA, QOL Medical LLC, McKesson Corporation, Kreussler, Inc., Provensis, ltd, STD Pharmaceuticals Product Ltd., Medtronic plc, Teleflex Incorporated, and Boston Scientific Corporation
North America is expected to hold the dominant position in the global market due to the growing prevalence of varicose veins disease. According to the National Center for Biotechnology Information (NCBI), 2019, 41% of people in the U.S. suffer from varicose veins and around 41% of women population and 50% of the men population all over the world, over the age of 50 have telangiectasia. According to NCBI, 2018, lower limb varicose veins are very common and over 10 – 30% of the worldwide population suffers from telangiectasia.
Microsclerotherapy, also known as radiation oncology, is the medical process used to cure spider veins or other varicose veins of the feet. It's a relatively simple procedure that involves injecting a small fluid into the affected veins which causes them to literally disintegrate over time and kills them off. It also can significantly reduce the appearance of spider veins and helps to improve circulation in the feet. This type of treatment for spider veins is highly effective, but you should be aware of several potential side effects. These may include swelling at the site of treatment, bruising, and scarring.
A microsclerosing procedure, performed by a certified physician, is recommended. The fluids will be injected into the affected areas using thin plastic syringes. In this type of injection microsclerotherapy treatment, the tiny needle-like injections are targeted at the main problem areas of larger veins in the body. For example, when treating spider veins, the microsclerosed solutions are injected into the superficial and deepest portions of the vein. Microsclerotherapy is an outpatient procedure that usually requires no special preparation for treatment and can be performed at home. One week after the treatment, a topical vasoconstrictor may be recommended, either alone or in combination with the microsclerotherapy solution.